Skip to content
Stay curious ↗

Follow your curiosity.

Try “brain”, “genomics”, or another subject you follow.

Today/Digital Health
Digital Health · The big question

Utah Halts AI Prescribing Pilot Over Safety Concerns

Opinion: AI doctors should be licensed. Here’s a framework to do that

STAT News1 min readAI-assisted summary
Editorial illustration for Opinion: AI doctors should be licensed. Here’s a framework to do that
Editorial illustration

Summary

Imagine chatting with a computer program instead of your doctor to get your daily medications refilled. In Utah, this scenario briefly became a reality. The state launched an early-stage pilot program with an artificial intelligence company called Doctronic. The project used a chatbot to evaluate patients and recommend prescription renewals for nearly 200 different drugs used to treat long-term, chronic conditions.

The state originally intended to phase out the need for a human physician to review every individual prescription renewal handled by the software. However, the Utah Medical Licensing Board stepped in and called for an immediate suspension of the program. The board warned that relying on the technology without proper clinical oversight potentially places citizens at risk. Readers should keep in mind that this news comes from an opinion piece about a single, early-stage state pilot program that was paused specifically due to these regulatory and safety concerns.

Why it matters.

This halted test program highlights a major debate over the future of medicine. As healthcare systems look for ways to increase efficiency and reduce the heavy workload on doctors, automated tools are becoming an attractive option for routine medical tasks. If successful, such programs could drastically change how patients interact with the healthcare system for basic needs. Yet, as the licensing board pointed out, removing human doctors from the loop brings immediate safety issues.

The swift suspension in Utah shows that medical regulators are deeply hesitant to hand over prescribing power to software. It signals to the healthcare industry that while artificial intelligence might offer convenience, regulatory bodies will demand strict clinical oversight to protect patients.

From the source

The story in numbers.

Chronic condition drugs eligible for chatbot prescription renewal
200
State pilot program suspended
1
Keep the context

Follow the evidence.

This AI-assisted summary is a starting point. Read the original reporting for its methods, scope, and limitations.

Your next discovery.

Keep exploring ↗
Digital Health

Upgraded medical AI can now request and analyze diverse diagnostic data.

Imagine chatting with a computer program that not only understands your symptoms but can also act like a medical detective. Researchers have developed a specialized artificial intelligence called the Articulate Medical Intelligence Explorer, or AMIE. This system is a large language model, which is a type of AI trained on vast amounts of text to understand and generate human language. Unlike general conversational programs, AMIE is custom-built specifically to hold diagnostic conversations with patients. Recent upgrades have given AMIE a powerful new set of skills. The AI can now handle multimodal medical data, meaning it can process different kinds of information at the same time. Instead of just passively receiving a list of symptoms, the upgraded system can actively ask for specific medical data, interpret those results, and use that combined information to logically think through a potential diagnosis.

Nature Medicine1 min read
Digital Health

New AI Tool Uses Retinal Scans to Detect Multiple Diseases

Researchers have developed a new artificial intelligence system designed to detect multiple diseases just by analyzing images of the eye. Known as Reti-Pioneer, this computer program examines scans of the retina, the light-sensitive tissue at the back of the eye. By reviewing these pictures, the AI can check for signs of several different health conditions all at once. To build this tool, the research team trained the AI using a massive collection of eye images gathered from various healthcare centers, ranging from local community clinics to large, specialized hospitals. This broad mix of data helps ensure the program works well for different types of patients. The creators then tested the system using outside data, confirming that it performs reliably beyond the original images it was trained on. The system has already been put to the test in real healthcare settings. Through an initial pilot study and a silent trial, where the AI ran in the background without affecting patient care, researchers showed that the tool is fast and practical for doctors to use. However, the study does not yet specify exactly which diseases the AI targets, the exact number of patients tested, or the precise accuracy rates of the diagnoses.

Nature Medicine1 min read
Digital Health

Supreme Court Preserves Telehealth Access to Mifepristone for Now

The Supreme Court has decided that mifepristone, a key medication used in medical abortions, can still be prescribed through telehealth and delivered by mail for the time being. This decision reverses a recent ruling by the 5th Circuit Court of Appeals, which had attempted to temporarily block doctors from prescribing the medication remotely. The legal dispute centers on safety protocols known as Risk Evaluation and Mitigation Strategies. Originally, these rules required patients to obtain mifepristone in person, but the Food and Drug Administration lifted those specific restrictions in 2021 to allow remote prescribing. The state of Louisiana is currently challenging this change in court, arguing that allowing doctors to prescribe the drug via telehealth directly undermines the state's strict abortion ban. It is important to note that the current Supreme Court decision is only a temporary measure. The broader case will continue to move its way through the justice system, meaning the ultimate legality of telehealth distribution for mifepristone remains highly uncertain.

STAT News1 min read

A little science goes a long way.

Clear, thoughtful biotech briefings. In your inbox three times a week.

Stay curious. Subscribe free ↗
Utah Halts AI Prescribing Pilot Over Safety Concerns — Daily Strand